MBHB Partner Josh Rich quoted in Bloomberg Law about the use of AI in the pharma industry

In Bloomberg Law, MBHB Partner Josh Rich discusses the intellectual property challenges AI-generated prior art poses for pharmaceutical companies. View the article.